Lannett Company Inc. is recalling approximately 25,680 bottles of Triamterene and Hydrochlorothiazide Capsules (37.5 mg/25 mg), a prescription medication used to treat high blood pressure and fluid retention. The recall was issued because the medication failed quality tests due to levels of impurities and degradation that exceeded safety specifications. There have been no reported incidents or injuries associated with these specific lots.
The presence of impurities or degradation products that exceed approved limits can compromise the safety and effectiveness of the medication. Taking medication that has degraded may not properly control blood pressure or swelling as intended.
You have 2 options:
Recall #: D-0160-2023; Quantity: 5,640 bottles
Recall #: D-0161-2023; Quantity: 20,040 bottles
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.